You are on page 1of 2

Images in Clinical Urology

Mesenteric Lymphadenopathy in Testicular


Germ Cell Tumor
Hooman Djaladat, Kamran Movassaghi, Hamed Ahmadi, Craig R. Nichols, and
Siamak Daneshmand
In approximately 25% of patients with testicular germ cell tumor (GCT), the cancer metastasizes to lymph nodes and
distant organs. The initial lymphatic drainage site of GCTs is the retroperitoneum. GCTs rarely involve mesenteric
lymph nodes. In this study, we report a case of a 32-year-old male patient with GCT and associated mesenteric
lymphadenopathy. UROLOGY 83: e7ee8, 2014.  2014 Elsevier Inc.

Figure 1. (A) Prechemotherapy computed tomographic scan


showing lesions in the retroperitoneal, intraperitoneal, and
mesenteric region. (B) Postchemotherapy computed tomo-
Figure 2. (A) Intraoperative photo showing mesenteric
graphic scan illustrating significant residual disease. A,
lymph node dissection with skeletonized vessels. (B)
aorta; LRA, left renal artery; LRV, left renal vein; RRA, right
Dissected specimens all consistent with mature cystic
renal artery; RRV, right renal vein.
teratoma.

Financial Disclosure: The authors declare that they have no relevant financial interests.

A
32-year-old man presented with worsening back
From the Institute of Urology, University of Southern California, Los Angeles, CA;
and the Virginia Mason Medical Center, Seattle, WA pain and hypertension. Massive retroperito-
Reprint requests: Siamak Daneshmand, M.D., Institute of Urology, University of neal and intraperitoneal masses with extension
Southern California, 1441 Eastlake Avenue, USC/Norris Comprehensive Cancer into the renal hilum and root of mesentery were seen
Center, Suite 7416, USC Institute of Urology, Los Angeles, CA 90089. E-mail:
siadaneshmand@yahoo.com in the computed tomographic scan Figure 1A. Tumor
Submitted: August 21, 2013, accepted (with revisions): November 4, 2013 markers were elevated (lactate dehydrogenase-790 IU/L,
ª 2014 Elsevier Inc. 0090-4295/14/$36.00 e7
All Rights Reserved http://dx.doi.org/10.1016/j.urology.2013.11.003
a-fetoprotein-2467 ng/mL, human chorionic pathways due to chemotherapy.3 Retroperitoneal histol-
gonadotropin-3979 U/mL). Scrotal ultrasound revealed a ogy might have implications on the management of
hypoechoic nodule in the right testis. Pathology from mesenteric LAD.4 If histology reveals necrosis/fibrosis,
orchiectomy showed pure seminoma. The patient was surveillance can be considered. In cases of teratoma,
diagnosed with stage III non-seminomatous germ cell most can be enucleated (Fig. 2), whereas others with
tumor (based on elevated AFP) and received chemo- more desmoplastic reaction can be biopsied at the time
therapy (3 cycles of bleomycin, etoposide, and plat- of retroperitoneal lymph node dissection (RPLND).
inum). Despite normalization of markers, computed
tomography as shown in Figure 1B illustrated disease
progression consistent with growing teratoma syndrome. References
Surgical resection of pelvic, retroperitoneal, and 1. Chen SF. Germ cell tumor of the testiseclinicopathologic analysis of
mesenteric masses was performed with special attention 114 cases. Chin J Oncol. 1985;7:277-279.
2. Park JM, Charnsangavej C, Wallace S, et al. Pathways of nodal
to bowel vasculature. Pathology revealed mature metastasis from pelvic tumors: CT demonstration. Radiographics.
teratoma. Fourteen months after surgery, the patient is 1994;14:1309-1321.
alive with minimal residual but stable peripancreatic 3. Pano B, Sebastia C, Nicolau C, et al. Pathways of lymphatic spread in
cystic masses. Mesenteric lymphadenopathy (LAD) in male urogenital pelvic malignancies. RadioGraphics. 2011;31:
patients with GCT has rarely been reported.1 Given the 135-160.
4. Steyerberg EW, Keizer HJ, Messemer JE, et al. Residual pulmonary
bulky retroperitoneal disease, mesenteric LAD can be masses after chemotherapy for metastatic nonseminomatous germ cell
explained by lymphatic backflow from the retro- tumor. Prediction of histology. ReHIT Study Group. Cancer. 1997;
peritoneum2 or disruption of lymphatic drainage 79:345-355.

e8 UROLOGY 83 (3), 2014

You might also like